Using imaging techniques to monitor cancer therapy effectiveness
Metabolic Imaging of Targeted Therapies in Cancer
This study is looking at new ways to see how well certain cancer treatments are working by checking changes in cancer cells, which could help doctors understand faster if the treatment is effective for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11025899 on NIH RePORTER |
What this research studies
This research focuses on developing advanced imaging methods to evaluate how well targeted cancer therapies, particularly small-molecule kinase inhibitors, are working in patients. By analyzing gene expression and metabolic changes in cancer cells, the study aims to identify specific biomarkers that indicate treatment response. The approach includes both laboratory experiments and non-invasive imaging techniques to track metabolic alterations in tumors over time. This could provide a more timely and accurate assessment of therapy effectiveness compared to traditional methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing targeted therapy who are interested in understanding their treatment response better.
Not a fit: Patients not receiving targeted therapies or those with non-cancerous conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring of cancer treatments, allowing for more personalized and effective patient care.
How similar studies have performed: Previous research has shown promise in using imaging techniques to monitor cancer therapies, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Nath, Kavindra — University of Pennsylvania
- Study coordinator: Nath, Kavindra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.